Upload
Featured Recent Articles Topics Login Upload

Search Results for 'Placebo-Evolocumab'

Placebo-Evolocumab published presentations and documents on DocSlides.

Trial Design Evolocumab SC
Trial Design Evolocumab SC
by danika-pritchard
140 mg Q2W or 420 mg QM. Placebo SC. Q2W or QM. L...
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
Long-term Tolerability and Efficacy of Evolocumab (AMG 145) in
by pamella-moone
Hyperlipidemic. Subjects: A 52 Week Phase 3 Dou...
Effect of the PCSK9 Inhibitor,
Effect of the PCSK9 Inhibitor,
by giovanna-bartolotta
Evolocumab. , on the Composition of Coronary Athe...
ACCP Cardiology PRN Journal Club
ACCP Cardiology PRN Journal Club
by phoebe-click
Dr. Courtney Montepara. Dr. Montepara completed h...
LDL Cholesterol Lowering with
LDL Cholesterol Lowering with
by shoffer
Evolocumab. and Outcomes in Patients with . Perip...
FOURIER F urther cardiovascular
FOURIER F urther cardiovascular
by trish-goza
OU. tcomes. . R. esearch with PCSK9 . I. nhibiti...
Placebo (n = 38) Metoprolol
Placebo (n = 38) Metoprolol
by unita
(. n . = 37). Metoprolol for AR. Primary endpoint,...
Fludrocortisone does not reduce the risk of recurrent syncope at 12 months compared with placebo i
Fludrocortisone does not reduce the risk of recurrent syncope at 12 months compared with placebo i
by delcy
syncope. Given the trend towards benefit though, i...
Placebo (n = 2,333) Empaglifozin
Placebo (n = 2,333) Empaglifozin
by SugarPlumFairy
(. n . = 4,687). EMPA-REG OUTCOME. Primary . outco...
Alpha Omega MACE: 14.0% with EPA-DHA vs. 13.8% with placebo (p = 0.93)
Alpha Omega MACE: 14.0% with EPA-DHA vs. 13.8% with placebo (p = 0.93)
by delcy
MACE: 13.2% with ALA vs. 14.5% with placebo (p = 0...
Neratinib / Placebo treatment
Neratinib / Placebo treatment
by heartersh
0. 3. 6. 9. 12. 15. 18. 21. 24. Disease-free survi...
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
ASCEND Randomized placebo-controlled trial of aspirin 100 mg daily in 15,480 patients with diabetes and no baseline cardiovascular
by mitsue-stanley
ASCEND Randomized placebo-controlled trial of as...
Causal diagrams, the placebo effect, and the expectation effect
Causal diagrams, the placebo effect, and the expectation effect
by ellena-manuel
Eyal Shahar, MD, MPH. Professor. (. c. redit to D...
Anxiolytic Placebo Response in Outbred Mice
Anxiolytic Placebo Response in Outbred Mice
by natalia-silvester
Kelsey I. . Landaverde. , Stacey L. . Kirkpatrick...
What Accounts for Placebo Group
What Accounts for Placebo Group
by alida-meadow
Improvements and Can They Be Reduced?. John T. Fa...
Does Meditation Really Work or It’s Placebo effect
Does Meditation Really Work or It’s Placebo effect
by ellena-manuel
Simge ALTINKÖK. Outline. Definition of meditati...
The Placebo Effect
The Placebo Effect
by danika-pritchard
. ...
The Placebo Effect
The Placebo Effect
by alexa-scheidler
Homeopathy. In the late 1700’s a German doctor ...
The Placebo Drift Debate in Antidepressant Clinical Trials
The Placebo Drift Debate in Antidepressant Clinical Trials
by celsa-spraggs
Zach Daniel White. Biology 101h- . Desaix. Why do...
PCSK9 Inhibition: LDL Lowering
PCSK9 Inhibition: LDL Lowering
by SweetiePie
PCSK9 inhibitors. New option for dyslipidemia. Ali...
LSU Journal Club Efficacy and Safety of
LSU Journal Club Efficacy and Safety of
by trish-goza
Evolocumab. in. Reducing Lipids and Cardiovascul...
HOT TOPICS IN CHOLESTEROL
HOT TOPICS IN CHOLESTEROL
by tatyana-admore
Are Statins as Effective in Women as in Men? Upda...
Figure 1 Figure 1. Estimated and observed viral load following treatment with placebo (A) or Paxlov
Figure 1 Figure 1. Estimated and observed viral load following treatment with placebo (A) or Paxlov
by gian
Bai Y, Du Z, Wang L, Lau E, Fung I, Holme P, et al...
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
TDF-FTC versus Placebo as HIV PrEP for Transgender Women
by shmuel184
iPrEx. Trial . Substudy. TDF-FTC versus Placebo a...
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
Learning Objectives Summarize the latest evidence on poly ADP ribose polymerase (PARP) inhibitors i
by zen
knowledge. ). Incorporate evidence-based research ...
Efficacy of Cariprazine on Cognitive Symptom Domains in Patients with Schizophrenia and Bipolar Dep
Efficacy of Cariprazine on Cognitive Symptom Domains in Patients with Schizophrenia and Bipolar Dep
by kolson
R. Csehi, . Zs. . B. Dombi. , . Á. Barabássy, B....
HIV Prevention England Conference
HIV Prevention England Conference
by felicity
18 February 2020. -. A two-stage randomised phase ...
Supplementing randomized clinical trials with historical data via Bayesian dynamic borrowing:
Supplementing randomized clinical trials with historical data via Bayesian dynamic borrowing:
by genevieve
A framework to engage with regulatory authorities....
Results from a Phase 2 Randomized, Placebo-Controlled, Double Blind Study of the
Results from a Phase 2 Randomized, Placebo-Controlled, Double Blind Study of the
by ella
Hedgehog Pathway Antagonist IPI-926 . in Patients ...
Rifaat Safadi 1 , John Lawler
Rifaat Safadi 1 , John Lawler
by ava
2. , Revital Aricha. 2. , Ilan Vaknin. 2. , Scott ...
Impact of Rosuvastatin on Atherosclerotic Progression in People with HIV at Moderate Cardiovascular
Impact of Rosuvastatin on Atherosclerotic Progression in People with HIV at Moderate Cardiovascular
by vivian
Janine Trevillyan. , Matthias . Cavassini. , Jan F...
Beyond A1c: Exploring the Expanding Role of Anti-Diabetic Agents
Beyond A1c: Exploring the Expanding Role of Anti-Diabetic Agents
by deena
Saidee Oberlander, PharmD, BCPS. Acute Care Pharma...
Safety and Antiviral Activity Over
Safety and Antiviral Activity Over
by bety
10 Days Following a Single Dose of Subcutaneous GS...
Thalidomide: Thalidomide is a medical drug that caused 
Thalidomide: Thalidomide is a medical drug that caused 
by skylar
unexpected and serious damage.  to unborn babies ...
Mark Whitlock Head of Statistics for Internal Medicine RU
Mark Whitlock Head of Statistics for Internal Medicine RU
by bethany
Early Clinical Devel. opment. Pfizer. Is High Plac...
DR.RAMYA S.S ASSISTANT PROFESSOR
DR.RAMYA S.S ASSISTANT PROFESSOR
by tremblay
DEPT OF HOMOEOPATHIC PHARMACY. PLACEBO. PLACEBO ...
Evidence Based Medicine In
Evidence Based Medicine In
by megan
Pharmacy Practice. Jarrod King, Pharm. D. . PGY1 U...
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor
Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor
by byrne
Overall survival and updated progression-free surv...
A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the trea
A randomized, double-blind, placebo-controlled study to assess efficacy of mirtazapine for the trea
by cora
1Department of Internal Medicine, School of Medici...
References (1) Epidemiology
References (1) Epidemiology
by jordyn
1. Queiroz LP, Peres MF, Piovesan EJ et al. . A na...